Development and validation of a highly accurate multigene gene expression biomarker to predict chemotherapy response in primary triple-negative breast cancer
Transcriptomic profiling combined with machine learning provides a promising approach for predicting NAC response in TNBC. The identified biomarkers may inform precision treatment strategies and improve clinical outcomes in this high-risk patient population.
Authors
- Soukaina Amniouel (ORCID: https://orcid.org/0009-0000-1428-8218)
- Mohsin Saleet Jafri
Institutions
- University of Maryland, Baltimore (US)
- George Mason University (US)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1007/s10549-026-07950-4
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00